Ipca Laboratories Limited (NSE:IPCALAB)
India · Delayed Price · Currency is INR 1,896.10
-7.40 (-0.39%)
Oct 23, 2026, 11:20 AM IST
Ipca Laboratories Market Cap
Ipca Laboratories has a market cap or net worth of 481.05 billion as of October 22, 2026. It is the 3,514th most valuable company in the world and the 199th biggest in India. Its market cap has increased by 47.98% in one year.
Market Cap
481.05B
Enterprise Value
491.78B
Revenue
101.26B
Global Rank
Country Rank
#199 India
PE Ratio
36.73
ChartMarket Cap Chart
Since June 12, 2002, Ipca Laboratories's market cap has increased from 3.22B to 481.05B, an increase of 14,845.20%. That is a compound annual growth rate of 22.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 481.05B | 33.63% |
| Dec 31, 2025 | 359.98B | -16.30% |
| Dec 31, 2024 | 430.08B | 52.29% |
| Dec 29, 2023 | 282.41B | 32.03% |
| Dec 30, 2022 | 213.90B | -22.18% |
| Dec 31, 2021 | 274.86B | -1.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Laurus Labs | 1.09T |
| Cipla | 1.06T |
| Mankind Pharma | 943.90B |
| Aurobindo Pharma | 908.41B |
| Glenmark Pharmaceuticals | 619.18B |
| Alkem Laboratories | 599.62B |
| Gland Pharma | 484.18B |
| Ajanta Pharma | 407.32B |